$1.37
-9.3%BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
STEX • NASDAQ
| Streamex Corp. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||
-462.8M | -10.3M | -28.7M | -27.3M | -32.9M | -52.2M | |
3.5M | 188K | 361K | 293K | 198K | 550K | |
-1.3M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
57.1M | 7M | 8M | 4.4M | 9.5M | 0.0 | |
392.9M | -1.9M | 2.3M | 388K | 209K | 22.7M | |
67K | 363K | 769K | 464K | -3.5M | 2.4M | |
-10.4M | -4.8M | -17.3M | -21.7M | -26.4M | -26.6M | |
INVESTING ACTIVITIES | ||||||
(0.0) | (0.0) | -186K | -168K | -542K | -87K | |
(366K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-24.6M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-24.3M | (0.0) | -186K | -168K | -542K | -87K | |
FINANCING ACTIVITIES | ||||||
10.2M | 4.2M | 15.4M | 10.4M | 10.3M | 42.8M | |
45.4M | 500K | 0.0 | 0.0 | 0.0 | 0.0 | |
-701K | 0.0 | 2M | 218K | 28K | 0.0 | |
54.9M | 4.7M | 17.3M | 10.6M | 10.3M | 42.8M | |
CASH FLOW SUMMARY | ||||||
-15K | 0.0 | 0.0 | 0.0 | 0.0 | 418.0 | |
20.2M | -48K | -167K | -11.3M | -16.6M | 16.2M | |
142K | 190K | 357K | 11.7M | 28.3M | 12.1M | |
20.3M | 142K | 190K | 357K | 11.7M | 28.3M | |
-10.4M | -4.8M | -17.5M | -21.9M | -26.9M | -26.7M |
STEX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 27, 2026 | May 26, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 04, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 08, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 20, 2026 | March 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 13, 2026 | February 09, 2026 | 2026 |
Continue your STEX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.